Serum metastasin mRNA is an important survival predictor in breast cancer

British Journal of Biomedical Science

Volumn 65, Issue 2, 2008, Pages 90-94

  El Abd, Eman ^a   El Tahan, R ^a   Fahmy, L ^a   Zaki, S ^a   Faid, W ^b   Sobhi, A ^a   Kandil, K ^c   El Kwisky, F ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

^b ALEXANDRIA UNIVERSITY   (Egypt)

^c Alexandria University Faculty Of Science   (Egypt)

Author keywords

Calcium binding proteins; Carcinoma, intraductal; Nucleic acids; Prognosis; S100A4 protein, human

Indexed keywords

CALVASCULIN; MESSENGER RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER SCREENING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY;

EID: 46249113028     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2008.11732804     Document Type: Article

References (42)

1. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977; 37: 646-50.
2. Stroun M, Anker R Maurice P, Lyautey J, Lederrey C, Beljanski M. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 1989; 46: 318-22.
3. Anker P, Mulcahy H, Chen XQ, Stroun M. Detection of circulating tumor DNA in the blood (plasma/serum) of cancer patients. Cancer Metast Rev 1999; 18 (Suppl): 65-73.
4. Kopreski MS, Benko FA, Kwak LW, Gocke CD. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res 1999; 5: 1961-5.
5. Chan KCA, Lo YMD. Circulating tumor-derived nucleic acids in Cancer patients: potential applications as tumor markers. Br J Cancer 2007; 96: 681-5.
6. Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer: a survey. Biochim Biophys Acta 2007; 1775: 181-232.
7. Reddi KK, Holland JF. Elevated serum ribonuclease in patients with pancreatic cancer. Proc Natl Acad Sci USA 1976; 73: 2308-10.
8. Tsui NB, Ng EK, Lo YMD. Stability of endogenous and added RNA in blood specimens, serum and plasma. Clin Chem 2002; 48: 1647-53.
9. Ng EK, Tsui NB, Lam NY et al. Presence of filterable and non-filterable mRNA in the plasma of cancer patients and healthy individuals. Clin Chem 2002; 48: 1212-7.
10. Yao R, Davidson DD, Lopez-Beltran A, MacLennan GT, Montironi R, Cheng L. The S100 proteins for screening and prognostic grading of bladder cancer. Histol Histopathol 2007; 22: 1025-32.
11. Tarabykina S, Griffiths TR, Tulchinsky E, Mellon JK, Bronstein IB, Kriajeyska M. Metastsis-associated protein S100A4: spotlight on its role in cell migration. Curr Cancer Drug Targets 2007; 7: 217-28.
12. Garrett SC, Varney KM, Weber DJ, Bresnick AR. S100A4, a mediator of metastasis. J Biol Chem 2006; 281: 677-80.
13. El-Abd E, Morsi M, Zaki S, Sobhi A. Relationship between serum hormones and angiogenesis with clinicopathological behaviour in Egyptian breast cancer. Bull Alex Fac Med 2003; 39: 257-64.
14. Haybittle JI, Blamey RW, Elstonc W et al. A prognostic index in primary breast cancer. Br J Cancer 1982; 45: 361-6.
15. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual 2nd edn. Cold Spring Harbor University Press, 1989.
16. Saad A, Sheta M, Sobhi A, Aly E, El-Abd E. Clinical and pathological assessment of sentinel lymph node micrometastasis in breast cancer using RT-PCR. J Egypt Soc Path 2005; 25: 81-7.
17. Rudland PS, Platt-Higgins A, Renshaw C et al. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res 2000; 60: 1595-603.
18. Ninomiya I, Ohta T, Fushida S et al. Increased expression of S100A4 and its prognostic significance in esophageal squamous cell carcinoma. Int J Oncol 2001; 18: 715-20.
19. Taylor S, Herrington S, Prime W, Rudland PS, Barraclough R. S100A4 (p9Ka) protein in colon carcinoma and liver metastases; association with carcinoma cells and T-lymphocytes. Br J Cancer 2002; 86: 409-16.
20. Rosty C, Ueki T, Argani P et al. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Am J Pathol 2002; 160: 45-50.
21. Kimura K, Endo Y, Yonemura Y et al. Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer. Int J Oncol 2000; 16: 1125-31.
22. Yonemura Y, Endou Y, Kimura K et al. Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clin Cancer Res 2000; 6: 4234-42.
23. Davies BR, O'Donnell M, Durkan GC et al. Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer. J Pathol 2002; 196: 292-9.
24. Barraclough R, Chen H, Davies BR et al. Use of DNA transfer in the induction of metastasis in experimental mammary systems. Biochem Soc Symp 1998; 63: 273-94.
25. Nikitenko LL, Lloyd BH, Rudland PS, Fear S, Barraclough R. Localisation by in situ hybridisation of S100A4 (p9Ka) mRNA in primary human breast tumour specimens. Int J Cancer 2000; 86: 219-28.
26. Cabezón T, Celis JE, Skibshøj I et al. Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer. Int J Cancer 2007; 121: 1433-44.
27. Chen XQ, Bonnefoi H, Felte M et al. Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin Cancer Res 2000; 6: 3823-6.
28. Sherbet GV, Lakshmi MS. S100A4 (MTS1) calcium binding protein in cancer growth, invasion and metastasis. Anticancer Res 1998; 18: 2415-22.
29. Albertazzi E, Cajone F, Leone BE, Naguib RN, Lakshmi MS, Sherbet GV. Expression of metastasis-associated genes h-mts1 (S100A4) and nm23 in carcinoma of breast is related to disease progression. DNA Cell Biol 1998; 17: 335-42.
30. Helfman DM, Kim EJ, Lukanidin E, Grigorian M. The metastasis-associated protein S100A4: role in tumor progression and metastasis. Br J Cancer 2005; 92: 1955-8.
31. Roberts DD. Regulation of tumor growth and metastasis by thrombospondin1. FASEB J 1996; 10: 1183-91.
32. Semov A, Moreno MJ, Onichtchenko A et al. Metastasis-associated protein S100A4 induces angiogenesis through interaction with annexin II and accelerated plasmin formation. J Biol Chem 2005; 280: 20833-41.
33. Pedrocchi M, Schäfer BW, Müller H, Eppenberger U, Heizmann CW. Expression of Ca(2+)-binding proteins of the S100 family in malignant human breast cancer cell lines and biopsy samples. Int J Cancer 1994; 57: 684-90.
34. Platt-Higgins AM, Renshaw CA, West CR et al. Comparison of the metastasis-inducing protein S100A4 (p9Ka) with other prognostic markers in human breast cancer. Int J Cancer 2000; 89: 198-208.
35. Barraclough R. Calcium-binding protein S100A4 in health and disease. Biochim Biophys Acta 1998; 1448: 190-9.
36. Pedersen KB, Nesland JM, Fodstad O, Maelandsmo GM. Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies. Br J Cancer 2002; 87: 1281-6.
37. Ambartsumian N, Klingelhofer J, Grigorian M et al. The metastasis-associated Mts1 (S100A4) protein could act as an angiogenic factor. Oncogene 2001; 20: 4685-95.
38. Flatmark K, Maelandsmo GM, Mikalsen SO et al. Immunofluorometric assay for the metastasis-related protein S100A4: release of S100A4 from normal blood cells prohibits the use of S100A4 as a tumor marker in plasma and serum. Tumour Biol 2004; 1-2: 31-40.
39. Lee WY, Su WC, Lin PW, Guo HR, Chang TW, Chen HH. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer. Oncology 2004; 66: 429-38.
40. Bjorland K, Winberg JO, Odegaard OT et al. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. Cancer Res 1999; 59: 4702-8.
41. Mandinova A, Atar D, Schafer BW, Spiess M, Aebi U, Heizmann CW. Distinct subcellular localization of calcium binding S100 proteins in human smooth muscle cells and their relocation in response to rises in intracellular calcium. J Cell Sci 1998; 111: 2043-54.
42. Grigorian MS, Tulchinsky EM, Zain S et al. The mts1 gene and control of tumour metastasis. Gene 1993; 135: 229-38.